Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company develops HLCM051, which is preparing for phase 3 clinical trial, as well as preparing for approval for the treatment of acute respiratory distress syndrome; HLCM051, which is in phase 2/3 and phase 3 clinical trial to treat ischemic stroke; and HLCM051, which is in phase 2 clinical trial to treat trauma. It also develo...
Industry: Biotechnology
Sector: Healthcare
Address:
Hibiya Mitsui Tower, WORK STYLING, 12 floor 1-1-2 Yurakucho Chiyoda-ku, Tokyo, Japan
